Detalhe da pesquisa
1.
A phase I, pharmacokinetic, and biological study of the farnesyltransferase inhibitor tipifarnib in combination with gemcitabine in patients with advanced malignancies.
Clin Cancer Res
; 9(13): 4761-71, 2003 Oct 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-14581347